AMETEK (AME) Earnings Call Highlights Record Year
Ametek Inc ((AME)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
AMETEK Delivers Record Results and Confident Outlook Despite Integration Headwinds
AMETEK’s latest earnings call carried a distinctly upbeat tone as management detailed a year and quarter filled with record performance across nearly every major financial metric. Sales, orders, operating income, EBITDA, EPS, and cash flow all reached new highs, while margins expanded and free cash flow conversion remained exceptionally strong. Executives acknowledged some manageable headwinds—mainly integration-related costs, higher taxes, and acquisition-driven amortization—but emphasized that robust organic momentum, disciplined capital deployment, and a healthy acquisition pipeline put the company on solid footing heading into 2026.
Record Quarterly and Annual Financial Results
AMETEK closed the year with its strongest quarter ever, posting Q4 sales of $2.0 billion, up 13% from the prior year, and full-year 2025 sales of $7.4 billion, up 7% versus 2024. Management highlighted that the company set quarterly records not only in sales but also in orders, operating income, EBITDA, diluted EPS, operating cash flow, and free cash flow. On a full-year basis, AMETEK established new highs in sales, operating income, operating margin, EBITDA, and diluted EPS, underscoring the resilience of its business model and its ability to grow profitably even amid choppy macro conditions.
Strong Orders, Backlog and Organic Momentum
Demand indicators were particularly impressive. Q4 orders reached a record $2.0 billion, up 18% year-over-year, with 7% organic order growth, driving the backlog to a record $3.58 billion. Management noted that sales and order growth strengthened throughout 2025, with Q4 being the best quarter of the year, and reported that order activity remained solid into January. This robust backlog and improving order trajectory suggest durable demand and provide good visibility into 2026 revenues, even as management remains mindful of potential macro volatility.
Profitability and Margin Expansion
Profitability continued to move higher. Q4 operating income hit a record $523 million, up 12% year-over-year, with an operating margin of 26.2%. On a core basis, operating margin reached 27.6%, an expansion of 100 basis points in the quarter. For the full year, core margins were up roughly 80 basis points, and Q4 EBITDA was $618 million, up 10%, with a 30.9% EBITDA margin. These results highlight AMETEK’s ability to drive operating leverage through cost discipline, pricing, and mix, even while absorbing incremental investments and acquisition-related dilution.
Record Cash Generation and Strong Cash Conversion
Cash performance was another standout. Q4 free cash flow came in at a record $527 million, up 6% year-over-year, translating to an impressive 132% conversion of net income. For the full year 2025, free cash flow totaled $1.7 billion, representing 113% of net income. Management guided to similarly strong conversion in 2026, in the 110%–115% range, reinforcing AMETEK’s reputation as a strong cash generator. This cash engine provides ample flexibility to fund organic investments, pursue acquisitions, return capital to shareholders, and still maintain a conservative balance sheet.
Earnings Per Share Execution
Earnings execution was another key theme. Q4 diluted EPS reached a record $2.01, up 7% from the prior year and ahead of guidance. Adjusting for an unusually low tax rate in the year-ago quarter, management noted that EPS was up roughly 11% on 5% organic sales growth, highlighting strong operating leverage. For full-year 2025, diluted EPS rose to $7.43, up 9% year-over-year. While upcoming tax and amortization headwinds will weigh on reported comparatives, the underlying earnings power of the business continues to trend higher.
Electromechanical Group: Broad-Based Segment Strength
The Electromechanical Group (EMG) delivered a particularly strong quarter, with Q4 sales of $629 million, up 15% year-over-year, driven by 14% organic growth. EMG operating income rose 28% to $142.5 million, and margins expanded sharply to 22.7%, an increase of 240 basis points. Management pointed to broad-based, double-digit organic growth across EMG divisions, underscoring the strength of the group’s niche positions and the benefit of AMETEK’s focus on high-value, differentiated electromechanical solutions.
Electronic Instruments Group: Steady Improvement Through the Year
The Electronic Instruments Group (EIG) also posted solid results, especially considering earlier-year softness in some end-markets. Q4 sales rose 13% to $1.37 billion, with organic sales turning positive at 2% as the year progressed. EIG operating income reached a record $413.7 million, up 7% year-over-year, and core operating margins improved to 32.3%, an increase of 50 basis points. Management highlighted the group’s margin resilience and the gradual improvement in underlying demand as key positives going into 2026.
Geographic and End‑Market Diversification
AMETEK’s diversified geographic and end-market exposure remains a strength. The company reported 10% growth in Asia, with China delivering low double-digit gains, and mid-single-digit growth in the U.S. and other international markets. Aerospace and defense was a notable outperformer, achieving low double-digit growth in Q4 and expected to deliver high single-digit organic growth in 2026. Process, power, and automation businesses showed improving trends after earlier weakness, helping to balance ongoing softness in more challenged niches such as research and certain oil & gas applications.
Active, Disciplined Capital Deployment
Capital allocation remained both active and disciplined in 2025. AMETEK deployed more than $1.8 billion, including acquisitions such as Ferro and Kern, approximately $443 million in share repurchases, and dividends. Despite this activity, the company still has the capacity to deploy more than $5 billion while preserving its investment-grade credit profile. Management reiterated that mergers and acquisitions remain the top priority for capital deployment and highlighted a strong, ongoing pipeline of potential deals, reinforcing AMETEK’s long-term growth-by-acquisition strategy.
Innovation Investment and Product Vitality
Management emphasized continued investment in innovation as a key driver of sustainable growth. In 2025, the company increased R&D, engineering, and sales-related spending by $90 million and plans another $100 million of incremental investment in 2026. AMETEK’s vitality index—measuring the share of sales from products launched in the last three years—stood at a robust 30% in Q4, underscoring healthy new-product contribution. Management called out new product families, such as those from Spectro, as evidence of strong commercial traction and a pipeline that should support future organic growth and pricing power.
Acquisition-Related Margin Dilution and Integration Costs
While acquisitions are central to AMETEK’s strategy, management was candid about near-term margin dilution from recent deals, notably FARO. These acquired businesses typically start with lower margins and require integration and restructuring to meet AMETEK’s standards. FARO currently operates at mid-teens EBITDA margins and incurred roughly $17.6 million of one-time integration and restructuring costs. Management expects it will take multiple years to lift FARO’s margins toward a roughly 30% target, meaning some temporary pressure on reported margins even as these assets contribute to long-term growth.
Tax Rate Increase and Future Tax Guidance
The company’s tax profile is becoming less of a tailwind. AMETEK’s effective tax rate rose to 16.3% in Q4 from 12.8% in 2024, with a full-year rate of 17.8%. For 2026, management expects the effective tax rate to be in the 18.5%–19.5% range. This higher tax burden will weigh on EPS growth versus periods when the company benefited from unusually low tax rates, and it is a key factor investors must consider when comparing year-over-year earnings performance.
Rising Depreciation and Amortization Pressure
Depreciation and amortization are also moving higher as a result of AMETEK’s acquisition strategy. Full-year D&A reached $1.423 billion, and for 2026 the company expects roughly $430 million of D&A, including approximately $210 million of after-tax acquisition-related intangible amortization, which equates to about $0.91 per diluted share. While these non-cash charges do not affect cash flow, they do pressure GAAP earnings metrics and contribute to a gap between reported earnings and the underlying cash-generating capacity of the business.
Higher Leverage but Still Conservative Balance Sheet
AMETEK’s balance sheet remains solid despite increased deal activity. Total debt rose to $2.3 billion, up $200 million year-over-year, largely due to the Ferro acquisition, while cash on hand stood at $458 million. Even with this uptick, leverage remains conservative, with gross debt to EBITDA around 1.0x and net leverage near 0.8x. Management views this as ample room to continue funding acquisitions and investments while preserving financial flexibility and maintaining an investment-grade rating.
Segment and Market Headwinds Earlier in the Year
Not all parts of the portfolio moved in lockstep. Process-related businesses saw negative or sluggish organic growth earlier in 2025 before improving to low-single-digit organic growth in Q4. Certain end markets, including research and oil & gas, remain softer and could moderate the pace of recovery in these process-oriented segments. Management’s commentary suggested cautious optimism: trends are improving, but normalization in these areas may be gradual rather than rapid.
Incremental Expense Increases and One-Time Items
The income statement also absorbed some incremental costs and one-time items. Q4 general and administrative expenses rose by $4 million, partly reflecting charitable donations, and full-year G&A increased by $10 million. Other expenses in Q4 were $6 million higher than the prior year. For 2026, management expects other operating expenses to be broadly in line with 2025, while cautioning that there may be near-term variability. These items are not large enough to derail the overall profitability story but do factor into quarterly margin noise.
Near-Term Margin Conservatism in Guidance
Despite strong recent incrementals, management is taking a cautious approach to margin guidance. For 2026, AMETEK is targeting about 30 basis points of core margin expansion and assuming reported incremental margins of roughly 35%, down from the stronger incrementals achieved in 2025. This conservatism reflects the near-term drag from acquisition integration, rising compensation, and investment spending, and suggests that while margins should still move higher, the pace of expansion may be more measured in the near term.
Macro and Geopolitical Risks Remain on the Radar
Management acknowledged that the macro backdrop remains uncertain. Risks include deglobalization trends, shifting tariff and trade dynamics, and lingering real estate-related weakness in China. While demand is improving and the backlog provides visibility, conversion of that backlog to revenue can vary significantly, historically ranging from 30% to 50%. AMETEK’s diversified portfolio and global footprint help mitigate these risks, but executives were clear that they are not assuming an overly benign macro environment in their planning.
Guidance Signals Continued Growth and Strong Cash Generation
Looking ahead to 2026, AMETEK is guiding to high-single-digit total sales growth, with organic sales expected to increase in the low- to mid-single-digit range. Diluted EPS is projected at $7.87 to $8.07, representing roughly 6%–9% growth over 2025, even after absorbing higher tax and amortization expenses. Q1 is expected to be strong, with sales up around 10% and adjusted EPS of $1.90–$1.95, also up 6%–9%. The company anticipates about 30 basis points of margin expansion for the year and reported incremental margins around 35%. The effective tax rate should land between 18.5% and 19.5%, G&A is expected to be roughly 1.5% of sales, and other operating expenses should be similar to 2025. Capital spending is forecast at about $160 million (roughly 2% of sales), and D&A around $430 million, including approximately $210 million of after-tax acquisition-related intangible amortization. Free cash flow conversion is expected to remain robust at 110%–115% of net income. Importantly for investors focused on capital deployment, management highlighted more than $5 billion of capacity for future investments while keeping leverage around 1.0x gross debt to EBITDA and maintaining an investment-grade profile.
In sum, AMETEK’s earnings call painted the picture of a company firing on all cylinders operationally and financially, with record results, expanding margins, and powerful cash generation underpinning a constructive outlook. While acquisitions, higher taxes, and amortization will temper reported margins and EPS optics in the near term, management’s disciplined capital allocation, commitment to innovation, and diversified end-market exposure leave the company well positioned for continued profitable growth. For investors, the story remains one of solid execution, conservative guidance, and a long runway for value creation through both organic initiatives and strategic M&A.
